Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Schizophrenia

  Free Subscription


Articles published in Am J Psychiatry

Retrieve available abstracts of 143 articles:
HTML format



Single Articles


    July 2021
  1. WEISER M, Davis JM, Brown CH, Slade EP, et al
    Differences in Antipsychotic Treatment Discontinuation Among Veterans With Schizophrenia in the U.S. Department of Veterans Affairs.
    Am J Psychiatry. 2021 Jul 14:appiajp202020111657.
    PubMed     Abstract available


  2. MARDER SR
    Changing the Face of Schizophrenia.
    Am J Psychiatry. 2021;178:584-585.
    PubMed    


    May 2021
  3. JOSHI YB, Thomas ML, Braff DL, Green MF, et al
    Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.
    Am J Psychiatry. 2021 May 14:appiajp202020081212.
    PubMed     Abstract available


  4. ANGLIN DM, Ereshefsky S, Klaunig MJ, Bridgwater MA, et al
    From Womb to Neighborhood: A Racial Analysis of Social Determinants of Psychosis in the United States.
    Am J Psychiatry. 2021 May 3:appiajp202020071091.
    PubMed     Abstract available


  5. HONER WG
    Better Evidence for Pharmacological Maintenance Treatment in Nonaffective Psychoses: Implications for Relapse Prevention.
    Am J Psychiatry. 2021;178:369-371.
    PubMed    


    April 2021
  6. AMSALEM D, Markowitz JC, Jankowski SE, Yang LH, et al
    Sustained Effect of a Brief Video in Reducing Public Stigma Toward Individuals With Psychosis: A Randomized Controlled Trial of Young Adults.
    Am J Psychiatry. 2021 Apr 26:appiajp202020091293.
    PubMed     Abstract available


    March 2021
  7. FERRARELLI F
    Sleep Abnormalities in Schizophrenia: State of the Art and Next Steps.
    Am J Psychiatry. 2021 Mar 17:appiajp202020070968.
    PubMed     Abstract available


  8. FAAY MDM, Sommer IE
    Risk and Prevention of Aggression in Patients With Psychotic Disorders.
    Am J Psychiatry. 2021;178:218-220.
    PubMed    


    February 2021
  9. OSTUZZI G, Bertolini F, Del Giovane C, Tedeschi F, et al
    Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
    Am J Psychiatry. 2021 Feb 18:appiajp202020071120.
    PubMed     Abstract available


    January 2021
  10. KRAKOWSKI M, Tural U, Czobor P
    The Importance of Conduct Disorder in the Treatment of Violence in Schizophrenia: Efficacy of Clozapine Compared With Olanzapine and Haloperidol.
    Am J Psychiatry. 2021 Jan 21:appiajp202020010052.
    PubMed     Abstract available


  11. KRAGULJAC NV, McDonald WM, Widge AS, Rodriguez CI, et al
    Neuroimaging Biomarkers in Schizophrenia.
    Am J Psychiatry. 2021 Jan 5:appiajp202020030340.
    PubMed     Abstract available


    December 2020
  12. KALIN NH
    Molecules and Circuits Implicated in Schizophrenia Provide Leads for Novel Treatments.
    Am J Psychiatry. 2020;177:1099-1102.
    PubMed    


  13. IYER SN, Anderson KK, Malla A, Shah J, et al
    The Case for Cautious Interpretation and Replication: Lead-Time Bias as a Potential Explanation for the Link Between Duration of Untreated Psychosis and Outcome.
    Am J Psychiatry. 2020;177:1180-1181.
    PubMed    


  14. DWIVEDI Y
    Cell-Type-Specific Transcriptomic Analysis in the Dorsolateral Prefrontal Cortex Reveals Distinct Mitochondrial Abnormalities in Schizophrenia and Bipolar Disorder.
    Am J Psychiatry. 2020;177:1107-1109.
    PubMed    


  15. JONAS KG, Fochtmann LJ, Perlman G, Tian Y, et al
    Lead-Time Bias as a Potential Explanation for the Link Between Duration of Untreated Psychosis and Outcome: Response to Iyer et al.
    Am J Psychiatry. 2020;177:1181-1183.
    PubMed    


  16. WOODS SW, Yung AR, McGorry PD, McGlashan TH, et al
    Duration of Untreated Psychosis: Getting Both the Timing and the Sample Right.
    Am J Psychiatry. 2020;177:1183.
    PubMed    


  17. JONAS KG, Fochtmann LJ, Perlman G, Tian Y, et al
    Duration of Untreated Psychosis: Getting Both the Timing and the Sample Right: Response to Woods et al.
    Am J Psychiatry. 2020;177:1183-1185.
    PubMed    


  18. COYLE JT, Ruzicka WB, Balu DT
    Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse.
    Am J Psychiatry. 2020;177:1119-1128.
    PubMed    


  19. BUCHANAN RW
    How Much of an Advance Is the Addition of Samidorphan to Olanzapine?
    Am J Psychiatry. 2020;177:1113-1114.
    PubMed    


  20. SRIHARI VH, Guloksuz S, Friis S
    Natural History, Not Lead Time.
    Am J Psychiatry. 2020;177:1185.
    PubMed    


  21. JONAS KG, Fochtmann LJ, Perlman G, Tian Y, et al
    Natural History, Not Lead Time: Response to Srihari et al.
    Am J Psychiatry. 2020;177:1185-1186.
    PubMed    


  22. FRISTON KJ
    Bayesian Dysconnections.
    Am J Psychiatry. 2020;177:1110-1112.
    PubMed    


    October 2020
  23. GLAUSIER JR, Enwright JF 3rd, Lewis DA
    Diagnosis- and Cell Type-Specific Mitochondrial Functional Pathway Signatures in Schizophrenia and Bipolar Disorder.
    Am J Psychiatry. 2020 Oct 29:appiajp202019111210.
    PubMed     Abstract available


    September 2020
  24. HUANG AS, Rogers BP, Sheffield JM, Jalbrzikowski ME, et al
    Thalamic Nuclei Volumes in Psychotic Disorders and in Youths With Psychosis Spectrum Symptoms.
    Am J Psychiatry. 2020 Sep 11:appiajp202019101099.
    PubMed     Abstract available


  25. KEEPERS GA, Fochtmann LJ, Anzia JM, Benjamin S, et al
    The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.
    Am J Psychiatry. 2020;177:868-872.
    PubMed    


  26. POST RM
    Early Detection and Preventive Treatment in Bipolar Disorder.
    Am J Psychiatry. 2020;177:867.
    PubMed    


    August 2020
  27. CORRELL CU, Newcomer JW, Silverman B, DiPetrillo L, et al
    Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study.
    Am J Psychiatry. 2020 Aug 14:appiajp202019121279.
    PubMed     Abstract available


    July 2020
  28. MUSLINER KL, Krebs MD, Albinana C, Vilhjalmsson B, et al
    Polygenic Risk and Progression to Bipolar or Psychotic Disorders Among Individuals Diagnosed With Unipolar Depression in Early Life.
    Am J Psychiatry. 2020 Jul 14:appiajp202019111195.
    PubMed     Abstract available


  29. DUGRE JR, Dumais A, Potvin S
    Limbic Hyperactivity in Response to Emotionally Neutral Stimuli in Schizophrenia: Response to Rasetti et al.
    Am J Psychiatry. 2020;177:640-641.
    PubMed    


  30. RASETTI R, Chen Q, Weinberger DR
    Comment on Limbic Hyperactivity in Response to Emotionally Neutral Stimuli in Schizophrenia: A Neuroimaging Meta-Analysis of the Hypervigilant Mind.
    Am J Psychiatry. 2020;177:639-640.
    PubMed    


  31. EISENBERG DP, Gregory MD, Berman KF
    Subcortical Signatures of Hemizygosity and Psychosis in 22q11.2 Deletion Syndrome: Finding Common Ground in Rare Genetic Variation.
    Am J Psychiatry. 2020;177:564-566.
    PubMed    


    June 2020
  32. HARVEY PD
    An Array of Studies Addressing Cognition and Cognitively Defined Neuropsychiatric Conditions: Many More Connections Than You Might Think.
    Am J Psychiatry. 2020;177:491-496.
    PubMed     Abstract available


    May 2020
  33. GREENMAN DLB, La MAN, Shah S, Chen Q, et al
    Parietal-Prefrontal Feedforward Connectivity in Association With Schizophrenia Genetic Risk and Delusions.
    Am J Psychiatry. 2020 May 27:appiajp202019111176.
    PubMed     Abstract available


    April 2020
  34. ZANELLI J, Mollon J, Sandin S, Reichenberg A, et al
    Are Visual Memory Deficits in Recent-Onset Psychosis Degenerative? Response to Smucny et al.
    Am J Psychiatry. 2020;177:356-357.
    PubMed    


  35. PANAYIOTOU A, Wood S, Stainton A, Van Rheenen T, et al
    Failing to Gain: Another Explanation of Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode.
    Am J Psychiatry. 2020;177:354.
    PubMed    


  36. ZANELLI J, Mollon J, Sandin S, Reichenberg A, et al
    Further Analysis of Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode: Response to Panayiotou et al.
    Am J Psychiatry. 2020;177:354-355.
    PubMed    


  37. SMUCNY J, Zarubin VC, Ragland JD, Carter CS, et al
    Are Visual Memory Deficits in Recent-Onset Psychosis Degenerative?
    Am J Psychiatry. 2020;177:355-356.
    PubMed    


  38. KAHN RS
    On the Origins of Schizophrenia.
    Am J Psychiatry. 2020;177:291-297.
    PubMed    


  39. LEWANDOWSKI KE
    Genetically, Developmentally, and Clinically Distinct Cognitive Subtypes in Schizophrenia: A Tale of Three Trajectories.
    Am J Psychiatry. 2020;177:282-284.
    PubMed    


  40. KALIN NH
    Psychotic Experiences, Cognitive Decline, and Genetic Vulnerabilities in Relation to Developing Psychotic Disorders.
    Am J Psychiatry. 2020;177:279-281.
    PubMed    


    March 2020
  41. HOLLERAN L, Kelly S, Alloza C, Agartz I, et al
    The Relationship Between White Matter Microstructure and General Cognitive Ability in Patients With Schizophrenia and Healthy Participants in the ENIGMA Consortium.
    Am J Psychiatry. 2020 Mar 26:appiajp201919030225.
    PubMed     Abstract available


  42. GOFF DC, Li C, Thorpe L
    Does Early Intervention Improve the Long-Term Course of Schizophrenia?
    Am J Psychiatry. 2020 Mar 4:appiajp202020020111.
    PubMed    


    February 2020
  43. JONAS KG, Fochtmann LJ, Perlman G, Tian Y, et al
    Lead-Time Bias Confounds Association Between Duration of Untreated Psychosis and Illness Course in Schizophrenia.
    Am J Psychiatry. 2020 Feb 12:appiajp201919030324.
    PubMed     Abstract available


  44. HJORTHOJ C, Starzer MSK, Benros ME, Nordentoft M, et al
    Infections as a Risk Factor for and Prognostic Factor After Substance-Induced Psychoses.
    Am J Psychiatry. 2020 Feb 12:appiajp201919101047.
    PubMed     Abstract available


  45. KALIN NH
    Treating Substance Use Disorders, Binge Eating, and Depression, and Identifying Factors Underlying Psychosis Risk.
    Am J Psychiatry. 2020;177:101-103.
    PubMed    


    January 2020
  46. KENDLER KS
    Maternal Bacterial Infection During Pregnancy: A Potential Causal Risk Factor for Psychosis in Offspring.
    Am J Psychiatry. 2020;177:14-16.
    PubMed    


  47. KALIN NH, Binder E, Brady KT, Lewis DA, et al
    2019 Articles of Import and Impact.
    Am J Psychiatry. 2020;177:17-19.
    PubMed    


    December 2019
  48. LEUCHT S, Crippa A, Siafis S, Patel MX, et al
    Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
    Am J Psychiatry. 2019 Dec 16:appiajp201919010034.
    PubMed     Abstract available


  49. DICKINSON D, Zaidman SR, Giangrande EJ, Eisenberg DP, et al
    Distinct Polygenic Score Profiles in Schizophrenia Subgroups With Different Trajectories of Cognitive Development.
    Am J Psychiatry. 2019 Dec 16:appiajp201919050527.
    PubMed     Abstract available


  50. RAGLAND JD
    Relating Basal and Phasic Hippocampal Activity in People With Psychosis: A Translational Bridge to Understanding Memory Deficits?
    Am J Psychiatry. 2019;176:979-981.
    PubMed    


    November 2019
  51. PERKINS DO, Olde Loohuis L, Barbee J, Ford J, et al
    Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk.
    Am J Psychiatry. 2019 Nov 12:appiajp201918060721.
    PubMed     Abstract available


    October 2019
  52. MCHUGO M, Talati P, Armstrong K, Vandekar SN, et al
    Hyperactivity and Reduced Activation of Anterior Hippocampus in Early Psychosis.
    Am J Psychiatry. 2019 Oct 18:appiajp201919020151.
    PubMed     Abstract available


  53. KARLSGODT KH
    Using Advanced Diffusion Metrics to Probe White Matter Microstructure in Individuals at Clinical High Risk for Psychosis.
    Am J Psychiatry. 2019;176:777-779.
    PubMed    


  54. KALIN NH
    Gaining Ground on Schizophrenia: Conceptualizing How to Use Neuroimaging and Genomics in Its Diagnosis and Treatment.
    Am J Psychiatry. 2019;176:771-773.
    PubMed    


  55. GUR RE, Gur RC
    Functional MRI Predicting Intervention Outcome in Early Psychosis.
    Am J Psychiatry. 2019;176:780-782.
    PubMed    


  56. BINDER EB
    Polygenic Risk Scores in Schizophrenia: Ready for the Real World?
    Am J Psychiatry. 2019;176:783-784.
    PubMed    


  57. LIEBERMAN JA, Small SA, Girgis RR
    Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality.
    Am J Psychiatry. 2019;176:794-810.
    PubMed     Abstract available


  58. KAHN RS
    On the Specificity of Continuous Cognitive Decline in Schizophrenia.
    Am J Psychiatry. 2019;176:774-776.
    PubMed    


    September 2019
  59. DUGRE JR, Bitar N, Dumais A, Potvin S, et al
    Limbic Hyperactivity in Response to Emotionally Neutral Stimuli in Schizophrenia: A Neuroimaging Meta-Analysis of the Hypervigilant Mind.
    Am J Psychiatry. 2019 Sep 6:appiajp201919030247.
    PubMed     Abstract available


  60. ALLSWEDE DM, Addington J, Bearden CE, Cadenhead KS, et al
    Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains.
    Am J Psychiatry. 2019 Sep 6:appiajp201918111290.
    PubMed     Abstract available


  61. APPELBAUM PS
    In Search of a New Paradigm for Research on Violence and Schizophrenia.
    Am J Psychiatry. 2019;176:677-679.
    PubMed    


  62. TANDON R, Shariff SM
    Substance-Induced Psychotic Disorders and Schizophrenia: Pathophysiological Insights and Clinical Implications.
    Am J Psychiatry. 2019;176:683-684.
    PubMed    


    August 2019
  63. ZHEUTLIN AB, Dennis J, Karlsson Linner R, Moscati A, et al
    Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia in 106,160 Patients Across Four Health Care Systems.
    Am J Psychiatry. 2019 Aug 16:appiajp201918091085.
    PubMed     Abstract available


    July 2019
  64. KOCHUNOV P, Huang J, Chen S, Li Y, et al
    White Matter in Schizophrenia Treatment Resistance.
    Am J Psychiatry. 2019 Jul 29:appiajp201918101212.
    PubMed     Abstract available


  65. ESCOTT-PRICE V, Pardinas AF, Santiago E, Walters J, et al
    The Relationship Between Common Variant Schizophrenia Liability and Number of Offspring in the UK Biobank: Response to Lawn et al.
    Am J Psychiatry. 2019;176:574-575.
    PubMed    


  66. CAO H, Cannon TD
    Cerebellar Dysfunction and Schizophrenia: From "Cognitive Dysmetria" to a Potential Therapeutic Target.
    Am J Psychiatry. 2019;176:498-500.
    PubMed    


  67. BULLMORE E
    Cortical Thickness and Connectivity in Schizophrenia.
    Am J Psychiatry. 2019;176:505-506.
    PubMed    


  68. LAWN RB, Sallis HM, Taylor AE, Wootton RE, et al
    Comment on the Relationship Between Common Variant Schizophrenia Liability and Number of Offspring in the UK Biobank.
    Am J Psychiatry. 2019;176:573-574.
    PubMed    


  69. SMUCNY J, Lesh TA, Carter CS
    Baseline Frontoparietal Task-Related BOLD Activity as a Predictor of Improvement in Clinical Symptoms at 1-Year Follow-Up in Recent-Onset Psychosis.
    Am J Psychiatry. 2019 Jul 1:appiajp201918101126.
    PubMed     Abstract available


  70. ZANELLI J, Mollon J, Sandin S, Morgan C, et al
    Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode.
    Am J Psychiatry. 2019 Jul 1:appiajp201918091088.
    PubMed     Abstract available


  71. HAWCO C, Buchanan RW, Calarco N, Mulsant BH, et al
    Separable and Replicable Neural Strategies During Social Brain Function in People With and Without Severe Mental Illness.
    Am J Psychiatry. 2019;176:521-530.
    PubMed     Abstract available


    June 2019
  72. TANG Y, Pasternak O, Kubicki M, Rathi Y, et al
    Altered Cellular White Matter But Not Extracellular Free Water on Diffusion MRI in Individuals at Clinical High Risk for Psychosis.
    Am J Psychiatry. 2019 Jun 24:appiajp201918091044.
    PubMed     Abstract available


  73. LIZANO P, Lutz O, Ling G, Lee AM, et al
    Association of Choroid Plexus Enlargement With Cognitive, Inflammatory, and Structural Phenotypes Across the Psychosis Spectrum.
    Am J Psychiatry. 2019 Jun 5:appiajp201918070825.
    PubMed     Abstract available


  74. WANNAN CMJ, Cropley VL, Chakravarty MM, Bousman C, et al
    Evidence for Network-Based Cortical Thickness Reductions in Schizophrenia.
    Am J Psychiatry. 2019 Jun 5:appiajp201918040380.
    PubMed     Abstract available


  75. MULLINS N, Bigdeli TB, Borglum AD, Coleman JRI, et al
    GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores.
    Am J Psychiatry. 2019 Jun 5:appiajp201918080957.
    PubMed     Abstract available


  76. PARDINAS AF, Nalmpanti M, Pocklington AJ, Legge SE, et al
    Pharmacogenomic Variants and Drug Interactions Identified Through the Genetic Analysis of Clozapine Metabolism.
    Am J Psychiatry. 2019;176:477-486.
    PubMed     Abstract available


    May 2019
  77. NUCIFORA LG, MacDonald ML, Lee BJ, Peters ME, et al
    Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia.
    Am J Psychiatry. 2019 May 6:appiajp201918070864.
    PubMed     Abstract available


  78. KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al
    Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample.
    Am J Psychiatry. 2019 May 6:appiajp201918101217.
    PubMed     Abstract available


    April 2019
  79. BUCHANAN A, Sint K, Swanson J, Rosenheck R, et al
    Correlates of Future Violence in People Being Treated for Schizophrenia.
    Am J Psychiatry. 2019 Apr 24:appiajp201918080909.
    PubMed     Abstract available


  80. VINOGRADOV S
    Has the Time Come for Cognitive Remediation in Schizophrenia...Again?
    Am J Psychiatry. 2019;176:262-264.
    PubMed    


    March 2019
  81. BEST MW, Milanovic M, Iftene F, Bowie CR, et al
    A Randomized Controlled Trial of Executive Functioning Training Compared With Perceptual Training for Schizophrenia Spectrum Disorders: Effects on Neurophysiology, Neurocognition, and Functioning.
    Am J Psychiatry. 2019 Mar 8:appiajp201818070849.
    PubMed     Abstract available


  82. MARTIN WF, Correll CU, Weiden PJ, Jiang Y, et al
    Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia.
    Am J Psychiatry. 2019 Mar 8:appiajp201818030280.
    PubMed     Abstract available


    February 2019
  83. SANCHEZ-ROIGE S, Palmer AA, Fontanillas P, Elson SL, et al
    Genome-Wide Association Study Meta-Analysis of the Alcohol Use Disorders Identification Test (AUDIT) in Two Population-Based Cohorts.
    Am J Psychiatry. 2019;176:107-118.
    PubMed     Abstract available


    January 2019
  84. BRADY RO JR, Gonsalvez I, Lee I, Ongur D, et al
    Cerebellar-Prefrontal Network Connectivity and Negative Symptoms in Schizophrenia.
    Am J Psychiatry. 2019 Jan 30:appiajp201818040429.
    PubMed     Abstract available


  85. JALBRZIKOWSKI M, Murty VP, Tervo-Clemmens B, Foran W, et al
    Age-Associated Deviations of Amygdala Functional Connectivity in Youths With Psychosis Spectrum Disorders: Relevance to Psychotic Symptoms.
    Am J Psychiatry. 2019 Jan 18:appiajp201818040443.
    PubMed     Abstract available


  86. ESCOTT-PRICE V, Pardinas AF, Santiago E, Walters J, et al
    The Relationship Between Common Variant Schizophrenia Liability and Number of Offspring in the UK Biobank.
    Am J Psychiatry. 2019 Jan 4:appiajp201818020140.
    PubMed     Abstract available


  87. WEINBERGER DR
    Polygenic Risk Scores in Clinical Schizophrenia Research.
    Am J Psychiatry. 2019;176:3-4.
    PubMed    


  88. WEINBERGER DR
    Thinking About Schizophrenia in an Era of Genomic Medicine.
    Am J Psychiatry. 2019;176:12-20.
    PubMed     Abstract available


    December 2018
  89. GHOSH A, Noble D
    The Influence of Unmeasured Confounding Effects in a Study of Antipsychotic Discontinuation in First-Episode Schizophrenia.
    Am J Psychiatry. 2018;175:1266-1267.
    PubMed    


    November 2018
  90. RIGLIN L, Hammerton G, Heron J, Collishaw S, et al
    Developmental Contributions of Schizophrenia Risk Alleles and Childhood Peer Victimization to Early-Onset Mental Health Trajectories.
    Am J Psychiatry. 2018 Nov 29:appiajp201818010075.
    PubMed     Abstract available


  91. BERGEN SE, Ploner A, Howrigan D, O'Donovan MC, et al
    Joint Contributions of Rare Copy Number Variants and Common SNPs to Risk for Schizophrenia.
    Am J Psychiatry. 2018 Nov 5:appiajp201817040467.
    PubMed     Abstract available


  92. ZHANG JP, Robinson D, Yu J, Gallego J, et al
    Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis.
    Am J Psychiatry. 2018 Nov 5:appiajp201817121363.
    PubMed     Abstract available


    October 2018
  93. MARTINEZ A, Gaspar PA, Hillyard SA, Andersen SK, et al
    Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications.
    Am J Psychiatry. 2018 Oct 3:appiajp201818010072.
    PubMed     Abstract available


  94. DI PRINZIO P, Morgan VA, Bjork J, Croft M, et al
    Intellectual Disability and Psychotic Disorders in Children: Association With Maternal Severe Mental Illness and Exposure to Obstetric Complications in a Whole-Population Cohort.
    Am J Psychiatry. 2018 Oct 3:appiajp201817101153.
    PubMed     Abstract available


    September 2018
  95. ZHANG T, Li H, Tang Y, Niznikiewicz MA, et al
    Validating the Predictive Accuracy of the NAPLS-2 Psychosis Risk Calculator in a Clinical High-Risk Sample From the SHARP (Shanghai At Risk for Psychosis) Program.
    Am J Psychiatry. 2018;175:906-908.
    PubMed    


    August 2018
  96. XIAO Y, Sun H, Shi S, Jiang D, et al
    White Matter Abnormalities in Never-Treated Patients With Long-Term Schizophrenia.
    Am J Psychiatry. 2018 Aug 2:appiajp201817121402.
    PubMed     Abstract available


  97. VERMEULEN JM, Schirmbeck F, Blankers M, van Tricht M, et al
    Association Between Smoking Behavior and Cognitive Functioning in Patients With Psychosis, Siblings, and Healthy Control Subjects: Results From a Prospective 6-Year Follow-Up Study.
    Am J Psychiatry. 2018 Aug 2:appiajp201818010069.
    PubMed     Abstract available


  98. KAHN RS
    On the Continued Benefit of Antipsychotics After the First Episode of Schizophrenia.
    Am J Psychiatry. 2018;175:712-713.
    PubMed    


    July 2018
  99. KRIVINKO JM, Erickson SL, Ding Y, Sun Z, et al
    Synaptic Proteome Compensation and Resilience to Psychosis in Alzheimer's Disease.
    Am J Psychiatry. 2018 Jul 19:appiajp201817080858.
    PubMed     Abstract available


  100. ROBERTSON AG, Easter MM, Lin H, Frisman LK, et al
    Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes.
    Am J Psychiatry. 2018;175:665-673.
    PubMed     Abstract available


    June 2018
  101. EL-MALLAKH RS, Furdek C
    Cycloid Psychosis.
    Am J Psychiatry. 2018;175:502-505.
    PubMed    


    May 2018
  102. NELSON JC, Bickford D, Delucchi K, Fiedorowicz JG, et al
    Risk of Psychosis in Recurrent Episodes of Psychotic and Nonpsychotic Major Depressive Disorder: A Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2018 May 24:appiajp201817101138.
    PubMed     Abstract available


  103. FARRELL M, Lichtenstein M, Crowley JJ, Filmyer DM, et al
    Developmental Delay, Treatment-Resistant Psychosis, and Early-Onset Dementia in a Man With 22q11 Deletion Syndrome and Huntington's Disease.
    Am J Psychiatry. 2018;175:400-407.
    PubMed    


  104. ROSENHECK R
    Toward Dissemination of Secondary Prevention for Psychosis.
    Am J Psychiatry. 2018;175:393-394.
    PubMed    


    April 2018
  105. TIIHONEN J, Tanskanen A, Taipale H
    20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia.
    Am J Psychiatry. 2018 Apr 6:appiajp201817091001.
    PubMed     Abstract available


  106. JEZEQUEL J, Lepleux M, Kahn RS, Honnorat J, et al
    Molecular Pathogenicity of Anti-NMDA Receptor Autoantibody From Patients With First-Episode Psychosis.
    Am J Psychiatry. 2018;175:382-383.
    PubMed    


  107. GHOSE S
    Substance-Induced Psychosis: An Indicator of Development of Primary Psychosis?
    Am J Psychiatry. 2018;175:303-304.
    PubMed    


  108. DAMIANI S, Fusar-Poli L
    The Cats of Louis Wain: A Thousand Ways to Draw One's Mind.
    Am J Psychiatry. 2018;175:315.
    PubMed    


    March 2018
  109. ANDERSON KK, Norman R, MacDougall A, Edwards J, et al
    Effectiveness of Early Psychosis Intervention: Comparison of Service Users and Nonusers in Population-Based Health Administrative Data.
    Am J Psychiatry. 2018 Mar 2:appiajp201717050480.
    PubMed     Abstract available


  110. KAUPPI K, Rosenthal SB, Lo MT, Sanyal N, et al
    Revisiting Antipsychotic Drug Actions Through Gene Networks Associated With Schizophrenia.
    Am J Psychiatry. 2018 Mar 2:appiajp201717040410.
    PubMed     Abstract available


  111. NOORDSY DL, Burgess JD, Hardy KV, Yudofsky LM, et al
    Therapeutic Potential of Physical Exercise in Early Psychosis.
    Am J Psychiatry. 2018;175:209-214.
    PubMed    


    February 2018
  112. PAYNE JL
    The Psychoses of Menstruation and Childbearingby Ian Brockington, M.D., F.R.C.P. Cambridge, England, Cambridge University Press, 2017, 391 pp., $140.00 (hardcover).
    Am J Psychiatry. 2018;175:190-191.
    PubMed    


  113. GOFF DC
    Optimizing the Pharmacologic Treatment of Individuals With First-Episode Psychosis.
    Am J Psychiatry. 2018;175:101-102.
    PubMed    


  114. ROBINSON DG, Schooler NR, Correll CU, John M, et al
    Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention.
    Am J Psychiatry. 2018;175:169-179.
    PubMed     Abstract available


    December 2017
  115. MCGUIRE P, Robson P, Cubala WJ, Vasile D, et al
    Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.
    Am J Psychiatry. 2017 Dec 15:appiajp201717030325.
    PubMed     Abstract available


  116. HAMILTON HK, Williams TJ, Ventura J, Jasperse LJ, et al
    Clinical and Cognitive Significance of Auditory Sensory Processing Deficits in Schizophrenia.
    Am J Psychiatry. 2017 Dec 5:appiajp201716111203.
    PubMed     Abstract available


    November 2017
  117. LIVNY A, Reichenberg A, Fruchter E, Yoffe R, et al
    A Population-Based Longitudinal Study of Symptoms and Signs Before the Onset of Psychosis.
    Am J Psychiatry. 2017 Nov 28:appiajp201716121384.
    PubMed     Abstract available


  118. STARZER MSK, Nordentoft M, Hjorthoj C
    Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis.
    Am J Psychiatry. 2017 Nov 28:appiajp201717020223.
    PubMed     Abstract available


  119. GOES FS, Sawa A
    Psychosis Beyond the 22q11.2 Deletion: Do Additional Genetic Factors Play a Role?
    Am J Psychiatry. 2017;174:1027-1029.
    PubMed    


  120. SCHOOLER NR
    Long-Term Outcomes of Psychosis: Naturalistic Follow-Up After Initial Hospitalization.
    Am J Psychiatry. 2017;174:1030-1031.
    PubMed    


  121. KOTOV R, Fochtmann L, Li K, Tanenberg-Karant M, et al
    Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project.
    Am J Psychiatry. 2017;174:1064-1074.
    PubMed     Abstract available


  122. VELTHORST E, Fett AJ, Reichenberg A, Perlman G, et al
    The 20-Year Longitudinal Trajectories of Social Functioning in Individuals With Psychotic Disorders.
    Am J Psychiatry. 2017;174:1075-1085.
    PubMed     Abstract available


    October 2017
  123. KANE JM
    Clozapine Reduces All-Cause Mortality.
    Am J Psychiatry. 2017;174:920-921.
    PubMed    


  124. RAHMAN T, Ash DM, Lauriello J, Rawlani R, et al
    Misleading Guidance From Pharmacogenomic Testing.
    Am J Psychiatry. 2017;174:922-924.
    PubMed    


    September 2017
  125. LEVITT JJ, Nestor PG, Levin L, Pelavin P, et al
    Reduced Structural Connectivity in Frontostriatal White Matter Tracts in the Associative Loop in Schizophrenia.
    Am J Psychiatry. 2017 Sep 15:appiajp201716091046.
    PubMed     Abstract available


    August 2017
  126. SANDOVAL LR, Torous J, Keshavan MS
    Smartphones for Smarter Care? Self-Management in Schizophrenia.
    Am J Psychiatry. 2017;174:725-728.
    PubMed    


    July 2017
  127. DAVIDSON M, Saoud J, Staner C, Noel N, et al
    Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
    Am J Psychiatry. 2017 Jul 28:appiajp201717010122.
    PubMed     Abstract available


  128. BASSETT AS, Lowther C, Merico D, Costain G, et al
    Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.
    Am J Psychiatry. 2017 Jul 28:appiajp201716121417.
    PubMed     Abstract available


  129. WIMBERLEY T, MacCabe JH, Laursen TM, Sorensen HJ, et al
    Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia.
    Am J Psychiatry. 2017 Jul 28:appiajp201716091097.
    PubMed     Abstract available


  130. ANDREASSEN OA
    Diabetes and Schizophrenia-New Findings for an Old Puzzle.
    Am J Psychiatry. 2017;174:616-617.
    PubMed    


  131. PHILIP NS, Nelson BG, Frohlich F, Lim KO, et al
    Low-Intensity Transcranial Current Stimulation in Psychiatry.
    Am J Psychiatry. 2017;174:628-639.
    PubMed     Abstract available


  132. SHARMA A, Wolf DH, Ciric R, Kable JW, et al
    Common Dimensional Reward Deficits Across Mood and Psychotic Disorders: A Connectome-Wide Association Study.
    Am J Psychiatry. 2017;174:657-666.
    PubMed     Abstract available


    June 2017
  133. COYLE JT
    Cortical Pyramidal Neurons Show a Selective Loss of New Synapses in Chronic Schizophrenia.
    Am J Psychiatry. 2017;174:510-511.
    PubMed    


    May 2017
  134. LEUCHT S, Leucht C, Huhn M, Chaimani A, et al
    Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors.
    Am J Psychiatry. 2017 May 25:appiajp201716121358.
    PubMed     Abstract available


  135. GOFF DC, Falkai P, Fleischhacker WW, Girgis RR, et al
    The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia.
    Am J Psychiatry. 2017 May 5:appiajp201716091016.
    PubMed     Abstract available


  136. HORVITZ-LENNON M, Mattke S, Predmore Z, Howes OD, et al
    The Role of Antipsychotic Plasma Levels in the Treatment of Schizophrenia.
    Am J Psychiatry. 2017;174:421-426.
    PubMed    


  137. NAKIMULI-MPUNGU E
    Our Most Troubling Madness: Case Studies in Schizophrenia Across Culturesedited by T.M. Luhrmann and Jocelyn Marrow. Oakland, University of California Press, 2016, 304 pp., $29.95 (paperback).
    Am J Psychiatry. 2017;174:490.
    PubMed    


  138. HAUSER RA, Factor SA, Marder SR, Knesevich MA, et al
    KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
    Am J Psychiatry. 2017;174:476-484.
    PubMed     Abstract available


  139. BOU KHALIL R
    On the Magical Thinking Related to Mental Health in Chad.
    Am J Psychiatry. 2017;174:427-428.
    PubMed    


    April 2017
  140. ROSENHECK RA, Estroff SE, Sint K, Lin H, et al
    Incomes and Outcomes: Social Security Disability Benefits in First-Episode Psychosis.
    Am J Psychiatry. 2017 Apr 21:appiajp201716111273.
    PubMed     Abstract available


  141. LAVRETSKY H
    Hallucinations Predict Relapse After Discontinuation of Risperidone in Patients With Alzheimer's Disease and Psychosis or Agitation.
    Am J Psychiatry. 2017;174:307-308.
    PubMed    


    March 2017
  142. MACDONALD ML, Alhassan J, Newman JT, Richard M, et al
    Selective Loss of Smaller Spines in Schizophrenia.
    Am J Psychiatry. 2017 Mar 31:appiajp201716070814.
    PubMed     Abstract available


  143. PATERSON C, Wang Y, Hyde TM, Weinberger DR, et al
    Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.
    Am J Psychiatry. 2017;174:256-265.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: